AAAAAA

   
Results: 1-14 |
Results: 14
Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study
Authors: Mahalati, K Belitsky, P West, K Kiberd, B Fraser, A Sketris, I Macdonald, AS McAlister, V Lawen, J
Citation: K. Mahalati et al., Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study, J AM S NEPH, 12(4), 2001, pp. 828-833
Clinical pharmacokinetics of sirolimus
Authors: Mahalati, K Kahan, BD
Citation: K. Mahalati et Bd. Kahan, Clinical pharmacokinetics of sirolimus, CLIN PHARMA, 40(8), 2001, pp. 573-585
Sirolimus permits steroid withdrawal from a cyclosporine regimen
Authors: Mahalati, K Kahan, BD
Citation: K. Mahalati et Bd. Kahan, Sirolimus permits steroid withdrawal from a cyclosporine regimen, TRANSPLAN P, 33(1-2), 2001, pp. 1270-1270
Sirolimus-tacrolimus combination immunosuppression
Authors: McAlister, VC Gao, ZH Peltekian, K Domingues, J Mahalati, K MacDonald, AS
Citation: Vc. Mcalister et al., Sirolimus-tacrolimus combination immunosuppression, LANCET, 355(9201), 2000, pp. 376-377
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity moreaccurately than trough levels
Authors: Mahalati, K Belitsky, P West, K Kiberd, B MacDonald, A McAlister, V Lawen, J
Citation: K. Mahalati et al., A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity moreaccurately than trough levels, TRANSPLAN P, 32(4), 2000, pp. 786-787
Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience
Authors: Dominguez, J Mahalati, K Kiberd, B McAlister, VC MacDonald, AS
Citation: J. Dominguez et al., Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience, TRANSPLANT, 70(8), 2000, pp. 1244-1247
Is routine ureteric stenting needed in kidney transplantation? A randomized trial
Authors: Dominguez, J Clase, CM Mahalati, K MacDonald, AS McAlister, VC Belitsky, P Kiberd, B Lawen, JG
Citation: J. Dominguez et al., Is routine ureteric stenting needed in kidney transplantation? A randomized trial, TRANSPLANT, 70(4), 2000, pp. 597-601
Bronchiolitis obliterans and organizing pneumonia in renal transplant recipients
Authors: Mahalati, K Murphy, DM West, ML
Citation: K. Mahalati et al., Bronchiolitis obliterans and organizing pneumonia in renal transplant recipients, TRANSPLANT, 69(7), 2000, pp. 1531-1532
Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
Authors: Mahalati, K Lawen, J Kiberd, B Belitsky, P
Citation: K. Mahalati et al., Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?, J UROL, 163(1), 2000, pp. 37-41
The management of brain metastasis in nonseminomatous germ cell tumours
Authors: Mahalati, K Bilen, CY Ozen, H Aki, FT Kendi, S
Citation: K. Mahalati et al., The management of brain metastasis in nonseminomatous germ cell tumours, BJU INT, 83(4), 1999, pp. 457-461
Persistant pre-eclampsia post partum with elevated liver enzymes and hemolytic uremic syndrome
Authors: Mahalati, K Ben Dawson, R Collins, JO Bell, WR McCrae, KR Martin, JN
Citation: K. Mahalati et al., Persistant pre-eclampsia post partum with elevated liver enzymes and hemolytic uremic syndrome, J CLIN APH, 14(2), 1999, pp. 69-78
Predictable recovery from myasthenia gravis crisis with plasma exchange: Thirty-six cases and review of current management
Authors: Mahalati, K Ben Dawson, R Collins, JO Mayer, RF
Citation: K. Mahalati et al., Predictable recovery from myasthenia gravis crisis with plasma exchange: Thirty-six cases and review of current management, J CLIN APH, 14(1), 1999, pp. 1-8
Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve
Authors: Belitsky, P Mahalati, K West, K Sketris, I
Citation: P. Belitsky et al., Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve, TRANSPLAN P, 31(3), 1999, pp. 1667-1668
Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation
Authors: Mahalati, K Belitsky, P Sketris, I West, K Panek, R
Citation: K. Mahalati et al., Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation, TRANSPLANT, 68(1), 1999, pp. 55-62
Risultati: 1-14 |